Have a personal or library account? Click to login
MOLECULAR CYTOGENETIC STUDY OF THE NF2 GENE DELETION IN MENINGIOMA IN SUDANESE PATIENTS Cover

MOLECULAR CYTOGENETIC STUDY OF THE NF2 GENE DELETION IN MENINGIOMA IN SUDANESE PATIENTS

Open Access
|Mar 2014

References

  1. 1. Zang KD. Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet. 2001; 93(3-4): 207-220.10.1159/000056986
  2. 2. Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol. 2010; 99(3): 307-314.10.1007/s11060-010-0386-3
  3. 3. Zankl H, Zang KD. Correlations between clinical and cytogenetical data in 180 meningiomas. Cancer Genet Cytogenet. 1980; 1(1): 351-356.10.1016/0165-4608(80)90044-8
  4. 4. Louis DN, Ramesh V, Gusella JF. Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol. 1995; 5(2): 163-172.10.1111/j.1750-3639.1995.tb00590.x
  5. 5. Capodano AM. Nervous system: meningioma. Atlas Genet Cytogenet Oncol Haematol. July 2000 (http://Atlas GeneticsOncology.org/Tumors/ meningiomasID5014. html).
  6. 6. Verma RS, Babu A. Human Chromosomes: Principles and Techniques: A Manual of Basic Techniques. New York: McGraw-Hill Professional, 1995.
  7. 7. Liehr T. Fluorescence In Situ Hybridization (FISH) Application Guide. Berlin: Springer, 2009.10.1007/978-3-540-70581-9
  8. 8. Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Stangeby C, Husain M. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg. 2004; 101(2): 210-218.10.3171/jns.2004.101.2.0210
  9. 9. Espinosa AB, Tabernero MD, Maíllo A, Sayagués JM, Ciudad J, Merino M, et al. The cytogenetic relationship between primary and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapse. Clin Cancer Res. 2006; 12(3 Pt 1): 772-780.10.1158/1078-0432.CCR-05-1480
  10. 10. Griffin CA, Hruban RH, Long PP, Miller N, Volz P, Carson B, et al. Chromosome abnormalities in meningeal neoplasms: do they correlate with histology? Cancer Genet Cytogenet. 1994; 78(1): 46-52.10.1016/0165-4608(94)90045-0
  11. 11. Lekanne Deprez RH, Riegman PH, van Drunen E, Warringa UL, Groen NA, Stefanko SZ, et al. Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas. J Neuropathol Exp Neurol. 1995; 54(2): 224-235.10.1097/00005072-199503000-000097876890
  12. 12. Sondak VK, Swetter SM, Berwick MA. Gender disparities in patients with melanoma: breaking the glass ceiling. J Clin Oncol. 2012; 30(18): 2177-2178.10.1200/JCO.2011.41.384922547593
  13. 13. Shen Y, Nunes F, Stemmer-Rachamimov A, James M, Mohapatra G, Plotkin S, et al. Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas. BMC Med Genomics. 2009; 2: 42 10.1186/1755-8794-2-42271636219589153
Language: English
Page range: 29 - 32
Published on: Mar 11, 2014
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2014 Y. AbdElmontalab Farah, I. Fadl Elmula, Hm. Abushama, K. Kreskowski, T. Liehr, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons License.